Therapeutic treatment for renal dysfunction

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/407 (2006.01) A61K 31/00 (2006.01) A61K 31/40 (2006.01)

Patent

CA 2323172

A method for treating renal dysfunctions is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((2"-ethoxy)-3'''(O)-4'''- (N,N-dimethylamino)-butane)-bis-(3,3'-indoly1)]-1(H)-pyrrole-2,5- dionehydrochloridesalt.

Cette invention se rapporte à un procédé servant à traiter les dysfonctions rénales, utilisant notamment l'inhibiteur de PKC (protéine-kinase C) sélectif des isozymes, le sel hydrochlorure de (S)-3,4-[N,N'-1,1'-((2''-éthoxy)-3'''(O)-4'''-(N,N-diméthylamino)-butane-bis-(3,3'-indolyl)]-1(H)pyrrole-2,5-dione.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic treatment for renal dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic treatment for renal dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment for renal dysfunction will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1425956

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.